Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"7,187 (4,926, 8,972)","36.9% (24.8%, 49.3%)","72.7% (58.6%, 87.0%)","17.3% (12.3%, 23.2%)","94.6% (90.8%, 96.3%)","12.9 (8.7, 17.2)","25.4 (20.5, 30.5)","6.0 (4.3, 8.1)","33.1 (31.8, 33.7)",,,,,
"(p=None, None), q=(None, None), c=0.500)","7,499 (5,199, 9,351)","44.7% (32.7%, 64.6%)","67.5% (53.0%, 83.1%)","15.3% (10.8%, 21.6%)","95.4% (92.6%, 97.3%)","15.6 (11.4, 22.6)","23.6 (18.6, 29.1)","5.3 (3.8, 7.6)","33.4 (32.4, 34.1)","4.4% (1.0%, 9.1%)","21.4% (5.0%, 49.9%)","-7.3% (-12.8%, -2.5%)","-11.5% (-18.8%, -4.6%)","0.8% (-2.1%, 3.3%)"
"(p=None, None), q=(None, None), c=0.750)","7,686 (5,430, 9,627)","45.2% (34.9%, 64.0%)","65.8% (51.7%, 80.9%)","14.6% (10.2%, 21.0%)","95.3% (92.9%, 97.4%)","15.8 (12.2, 22.4)","23.0 (18.1, 28.3)","5.1 (3.6, 7.4)","33.4 (32.5, 34.1)","7.1% (2.4%, 12.0%)","23.2% (5.1%, 49.2%)","-9.6% (-17.0%, -4.7%)","-15.6% (-25.1%, -7.3%)","0.7% (-1.7%, 3.4%)"
"(p=None, None), q=(None, None), c=1.000)","7,890 (5,593, 9,874)","45.8% (34.9%, 64.0%)","64.5% (50.0%, 81.2%)","13.9% (9.9%, 20.1%)","95.3% (92.9%, 97.2%)","16.0 (12.2, 22.4)","22.6 (17.5, 28.4)","4.9 (3.5, 7.0)","33.3 (32.5, 34.0)","10.0% (2.6%, 16.8%)","24.8% (5.4%, 46.9%)","-11.6% (-21.2%, -4.1%)","-19.7% (-29.9%, -8.4%)","0.7% (-1.5%, 3.1%)"
